{"id":"https://openalex.org/W2501149688","doi":"https://doi.org/10.1158/1538-7445.am2016-1498","title":"Abstract 1498: Development of an IL13Ralpha2 x CD3 bispecific DART\u00ae protein for redirected T-cell killing of solid tumors","display_name":"Abstract 1498: Development of an IL13Ralpha2 x CD3 bispecific DART\u00ae protein for redirected T-cell killing of solid tumors","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2501149688","doi":"https://doi.org/10.1158/1538-7445.am2016-1498","mag":"2501149688"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-1498","doi":"https://doi.org/10.1158/1538-7445.am2016-1498","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-1498","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049437942","display_name":"Jill R. Rillema","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Rillema","raw_affiliation_strings":["1MacroGenics, Inc., San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MacroGenics, Inc., San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037353634","display_name":"Monica Licea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Licea","raw_affiliation_strings":["1MacroGenics, Inc., San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MacroGenics, Inc., San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043686629","display_name":"Shereen Saini-Lal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shereen Saini-Lal","raw_affiliation_strings":["1MacroGenics, Inc., San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MacroGenics, Inc., San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040843630","display_name":"Doug Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Doug Smith","raw_affiliation_strings":["1MacroGenics, Inc., San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MacroGenics, Inc., San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025376488","display_name":"Francine Chen","orcid":"https://orcid.org/0000-0001-8459-6304","observed_orcids":["https://orcid.org/0000-0001-8459-6304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francine Chen","raw_affiliation_strings":["1MacroGenics, Inc., San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MacroGenics, Inc., San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Annie Lam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annie Lam","raw_affiliation_strings":["1MacroGenics, Inc., San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MacroGenics, Inc., San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118788581","display_name":"Yinhua Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yinhua Yang","raw_affiliation_strings":["2MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005053576","display_name":"Liqin Liu","orcid":"https://orcid.org/0000-0001-7158-6772","observed_orcids":["https://orcid.org/0000-0001-7158-6772","https://orcid.org/0000-0001-5436-1790","https://orcid.org/0009-0004-2886-3905"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liqin Liu","raw_affiliation_strings":["2MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016101772","display_name":"James K. Tamura","orcid":"https://orcid.org/0000-0002-0463-2932","observed_orcids":["https://orcid.org/0000-0002-0463-2932"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Tamura","raw_affiliation_strings":["2MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110185766","display_name":"Ralph F. Alderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Alderson","raw_affiliation_strings":["2MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009027578","display_name":"Ezio Bonvini","orcid":"https://orcid.org/0000-0001-9054-3137","observed_orcids":["https://orcid.org/0000-0001-9054-3137"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ezio Bonvini","raw_affiliation_strings":["2MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031117799","display_name":"Syd Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syd Johnson","raw_affiliation_strings":["2MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023294934","display_name":"Paul A. Moore","orcid":"https://orcid.org/0000-0001-6057-7539","observed_orcids":["https://orcid.org/0000-0001-6057-7539"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Moore","raw_affiliation_strings":["2MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"1498","last_page":"1498"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9340999722480774,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9340999722480774,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.8370000123977661},{"id":"https://openalex.org/keywords/double-asteroid-redirection-test","display_name":"DART","score":0.5120000243186951},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.7990000247955322},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8040000200271606},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.7229999899864197},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.7049999833106995},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.5669999718666077},{"id":"https://openalex.org/keywords/fc-domain","display_name":"Fc domain","score":0.48399999737739563},{"id":"https://openalex.org/keywords/humanization","display_name":"humanization","score":0.6460000276565552},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.5630000233650208},{"id":"https://openalex.org/keywords/car-t","display_name":"CAR-T","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5862316489219666},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5850789546966553},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5841171145439148},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.509292721748352},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4884609282016754},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.4807179272174835},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4588225185871124},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4542075991630554},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3941269516944885},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.38879117369651794},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35677358508110046},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.25613561272621155},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10925173759460449}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-1498","doi":"https://doi.org/10.1158/1538-7445.am2016-1498","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-1498","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7163048748","https://openalex.org/W7163052437","https://openalex.org/W7163020488","https://openalex.org/W7057357136","https://openalex.org/W7163035562","https://openalex.org/W7223095135","https://openalex.org/W2093415362","https://openalex.org/W4225984367","https://openalex.org/W4396517666","https://openalex.org/W2056678336"],"abstract_inverted_index":{"Abstract":[0],"Introduction.":[1],"IL13R\u03b12":[2,31,42,65,68,79,181,206,248,262,271,318,388,404],"is":[3,66],"a":[4,9,36,186,239,421],"membrane-bound":[5],"protein":[6,266,408,465],"expressed":[7],"on":[8,80],"number":[10],"of":[11,92,173,188,205,303,316,385,426,458,470,476,481],"malignant":[12],"tumors,":[13],"but":[14,310],"not":[15,311],"at":[16],"significant":[17],"levels":[18,204],"in":[19,57,90,155,208,300,357,366,395,398],"most":[20],"normal":[21,122,197],"tissues.":[22],"Clinically":[23],"tested":[24],"therapies":[25],"to":[26,32,49,77,217,228,257,415],"treat":[27],"cancer":[28,136],"by":[29,107,117,127],"targeting":[30,64],"date":[33],"have":[34],"included":[35],"ligand":[37],"toxin":[38],"conjugate":[39],"(IL13-PE)":[40],"and":[41,83,109,120,123,139,178,191,210,235,238,244,269,276,280,287,296,307,337,354,374,397],"directed":[43],"CAR-T":[44],"cells.":[45,94,292],"Both":[46],"strategies":[47],"appear":[48],"be":[50],"well":[51],"tolerated,":[52],"although":[53],"with":[54,135,160,167,202,220,312,349,371],"mixed":[55],"results":[56],"tumor":[58,81,93,124,199,331,334],"eradication.":[59],"An":[60],"alternative":[61],"strategy":[62],"for":[63,225,242,326,402,424,466,485],"an":[67,221,247,254,403,459],"x":[69,249,263,319,389,405,461],"CD3":[70,250,264,320,390,406,462],"Dual-Affinity":[71],"Re-Targeting":[72],"(DART\u00ae)":[73],"bispecific":[74,463],"molecule":[75,252,322,419],"designed":[76],"co-engage":[78],"cells":[82,86,143,148,164,306,335,353],"cytotoxic":[84,230],"T":[85,142,163,231,352],"through":[87],"CD3,":[88],"resulting":[89],"killing":[91,469],"Methods.":[95],"Mouse":[96],"monoclonal":[97],"antibodies":[98],"(mAbs)":[99],"were":[100,133,153,183,298,347],"generated":[101],"using":[102],"standard":[103],"immunization":[104],"protocols":[105],"followed":[106],"binding":[108,114,189],"epitope":[110,192],"binning":[111],"analyses.":[112],"Cell":[113],"was":[115,215,363,409],"performed":[116,134,154],"flow":[118],"cytometry":[119],"frozen":[121],"tissues":[125],"analyses":[126],"immunohistochemistry":[128],"(IHC).":[129],"In":[130,150],"vitro":[131,396],"studies":[132,152,412],"cell":[137,345],"lines":[138],"primary":[140],"human":[141,162,168,177,268,308,351,372],"or":[144,165,342],"peripheral":[145],"blood":[146],"mononuclear":[147],"(PBMCs).":[149],"vivo":[151,399],"immune-deficient":[156],"tumor-bearing":[157],"mice":[158,369],"co-implanted":[159],"activated":[161,350],"reconstituted":[166,370],"PBMCs.":[169],"Results.":[170],"A":[171],"panel":[172,214],"mAbs":[174],"that":[175],"bind":[176],"cynomolgus":[179,270],"monkey":[180],"proteins":[182],"selected,":[184],"representing":[185],"range":[187],"characteristics":[190],"diversity.":[193],"IHC":[194],"showed":[195],"favorable":[196],"vs":[198],"tissue":[200],"reactivity,":[201],"high":[203],"expression":[207],"glioblastoma":[209],"melanoma.":[211],"The":[212,261],"mAb":[213],"converted":[216],"DART":[218,251,265,321,391,407],"molecules":[219],"anti-CD3":[222],"arm,":[223],"assessed":[224],"the":[226,301,317,418,477,482],"ability":[227],"mediate":[229],"lymphocyte":[232],"(CTL)":[233],"activity":[234,283,401],"cytokine":[236],"release":[237],"lead":[240],"selected":[241],"humanization":[243],"engineering":[245],"into":[246],"incorporating":[253],"Fc":[255],"domain":[256],"prolong":[258],"circulating":[259],"half-life.":[260],"bound":[267],"(KD":[272],"=":[273],"0.64":[274],"nM":[275],"0.5":[277],"nM,":[278],"respectively)":[279],"mediated":[281],"CTL":[282],"against":[284],"LOX-IMVI":[285,338,377],"(melanoma)":[286],"SK-MES-1":[288],"(lung":[289],"adenocarcinoma)":[290],"target":[291,305],"Cytokines":[293],"(IFN-\u03b3,":[294],"IL-10,":[295],"TNF-\u03b1)":[297],"released":[299],"presence":[302],"IL13R\u03b12-expressing":[304],"PBMC,":[309],"PBMCs":[313,373],"alone.":[314],"Administration":[315],"(\u226450":[323],"\u03bcg/kg":[324,387],"IV":[325,383],"4":[327],"consecutive":[328],"days)":[329],"prevented":[330],"growth":[332],"when":[333],"(A375":[336],"melanoma,":[339],"U87":[340],"glioblastoma,":[341],"DAOY":[343],"medulloblastoma":[344],"lines)":[346],"co-mixed":[348],"implanted":[355],"subcutaneously":[356],"NOD/SCID/IL2gamma-chain":[358],"null":[359],"mice.":[360],"Tumor":[361],"eradication":[362],"also":[364],"observed":[365],"NOD/SCID/IL2gamma-chain/MHCI":[367],"KO":[368],"bearing":[375],"established":[376],"melanoma":[378],"tumors":[379],"following":[380],"2":[381],"weekly":[382],"doses":[384],"50":[386],"molecule.":[392],"Conclusions:":[393],"Robust":[394],"antitumor":[400],"demonstrated.":[410],"Additional":[411],"are":[413],"underway":[414],"further":[416],"characterize":[417],"as":[420],"development":[422],"candidate":[423],"treatment":[425],"IL13R\u03b12-positive":[427],"cancers.":[428],"Citation":[429],"Format:":[430],"Jill":[431],"Rillema,":[432],"Monica":[433],"Licea,":[434],"Shereen":[435],"Saini-Lal,":[436],"Doug":[437],"Smith,":[438],"Francine":[439],"Chen,":[440],"Annie":[441],"Lam,":[442],"Yinhua":[443],"Yang,":[444],"Liqin":[445],"Liu,":[446],"James":[447],"Tamura,":[448],"Ralph":[449],"Alderson,":[450],"Ezio":[451],"Bonvini,":[452],"Syd":[453],"Johnson,":[454],"Paul":[455],"Moore.":[456],"Development":[457],"IL13Ralpha2":[460],"DART\u00ae":[464],"redirected":[467],"T-cell":[468],"solid":[471],"tumors.":[472],"[abstract].":[473],"In:":[474],"Proceedings":[475],"107th":[478],"Annual":[479],"Meeting":[480],"American":[483],"Association":[484],"Cancer":[486,497],"Research;":[487],"2016":[488],"Apr":[489],"16-20;":[490],"New":[491],"Orleans,":[492],"LA.":[493],"Philadelphia":[494],"(PA):":[495],"AACR;":[496],"Res":[498],"2016;76(14":[499],"Suppl):Abstract":[500],"nr":[501],"1498.":[502]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-08-23T00:00:00"}